Compare Erasca Inc. Common Stock (ERAS) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs NOV Inc. Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.64 (market cap $5.40B), while NOV Inc. Common Stock trades at $18.94 (market cap $6.77B). The key difference: NOV Inc. Common Stock is the larger of the two by market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and NOV Inc. Common Stock for 0 Days on average.
| ERAS | NOV | |
|---|---|---|
Market Cap | $5.40B | $6.77B |
Volume | 9,533,185 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $22.47 | $21.71 |
52-Week Low | $2.20 | $12.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.18B | $7.93B |
Dividend Yield | — | 1.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
